Bisdiamine inhibits extracellular matrix formation and cell proliferation of atrioventricular mesenchyme from developing chick heart valves

Teratology

Volumn 59, Issue 3, 1999, Pages 148-155

  Choy, Michael ^a   Oltjen, Sharon L ^a   Moon, Anita J ^a   Armstrong, Margaret T ^b   Armstrong, Peter B ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISDIAMINE; DIAMINE; FIBRONECTIN; TERATOGENIC AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL TRUNK; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CHICK EMBRYO; CONTROLLED STUDY; EMBRYO; EXTRACELLULAR MATRIX; HEART ATRIOVENTRICULAR VALVE; HEART DEVELOPMENT; HEART SEPTUM DEFECT; MESENCHYME; NONHUMAN; PRIORITY JOURNAL; SERUM;

ANIMALIA;

EID: 0032899670     PISSN: 00403709     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9926(199903)59:3<148::AID-TERA6>3.0.CO;2-F     Document Type: Article

References (44)

1. Armstrong MT, Armstrong PB. 1978. Cell motility in fibroblast aggregates. J Cell Sci 33:37-52.
2. Armstrong PB, Armstrong MT. 1990. An instructive role for the interstitial matrix in tissue patterning: Tissue segregation and intercellular invasion. J Cell Biol 110:1439-1455.
3. Bockman DE, Redmond ME, Kirby ML. 1989. Alteration of early vascular development after ablation of cranial neural crest. Anat Rec 225:209-217.
4. Burn J, Takao A, Wilson D, Cross I, Momma K, Wadey R, Scambler P, Goodship J. 1993. Conotruncal anomaly face syndrome is associated with a deletion within chromosome 22q11. J Med Genet 30:822-824.
5. Chon Y, Ando M, Takao A. 1984. Conotruncal anomalies produced by nimustine hydrochloride or bis-diamine in chick. In: Takao A, Nora JJ, editors. Congenital heart disease: Cause and processes. Mount Kisco: Futura Publishing Company. p 237-247.
6. Choy M, Armstrong MT, Armstrong PB. 1990. Regulation of proliferation of embryonic heart mesenchyme: Role of transforming growth factor-beta 1 and the interstitial matrix. Dev Biol 141:421-425.
7. Choy M, Oltjen S, Ratcliff D, Armstrong M, Armstrong P. 1993. Fibroblast behavior in the embryonic chick heart. Dev Dyn 198:97-107.
8. Choy M, Oltjen SL, Otani YS, Armstrong MT, Armstrong PB. 1996. Fibroblast growth factor-2 stimulates embryonic cardiac mesenchymal cell proliferation. Dev Dyn 206:193-200.
9. Driscoll DA. 1994. Genetic basis of DiGeorge and velocardiofacial syndromes. Curr Opin Pediatr 6:702-706.
10. Fairbairn S, Gilbert R, Qjakian G, Schwimmer R, Quigley JP. 1985. The extracellular matrix of normal chick embryo fibrobasts: Its effect on transformed chick fibroblasts and its proteolytic degradation by the transformants. J Cell Biol 101:1790-1798.
11. Fukiishi Y, Morriss-Kay GM. 1992. Migration of cranial neural crest cells to the pharyngeal arches and heart in rat embryos. Cell Tissue Res 268:1-8.
12. Hamburger V, Hamilton HL. 1951. A series of normal stages in the development of the chick embryo. J Morphol 88:49-92.
13. Ito K, Sieber-Blum M. 1991. In vitro clonal analysis of quail cardiac neural crest development. Dev Biol 148:95-106.
14. Jakowlew SB, Dillard PJ, Winokur TS, Flanders KC, Sporn MB, Roberts AB. 1991. Expression of transforming growth factor-betas 1-4 in chicken embryo chondrocytes and myocytes. Dev Biol 143:135-148.
15. Jakowlew SB, Ciment G, Tuan RS, Sporn MB, Roberts AB. 1994. Expression of transforming growth factor-beta 2 and beta 3 mRNAs and proteins in the developing chicken embryo. Differentiation 55:105-118.
16. Kirby ML. 1989. Plasticity and predetermination of mesencephalic and trunk neural crest transplanted into the region of the cardiac neural crest. Dev Biol 134:402-412.
17. Kirby ML, Waldo KL. 1990. Role of neural crest in congenital heart disease. Circulation 82:332-340.
18. Kopriwa BM, Leblond CP. 1962. Improvements in the coating technique of radioautography. J Histochem Cytochem 10:269-284.
19. Korenberg JR, Kawashima H, Pulst SM, Ikeuchi T, Ogasawara N, Yamamoto K, Schonberg SA, West R, Allen L, Magenis E, Ikawa K, Taniguchi N, Epstein C. 1990. Molecular definition of a region of chromosome 21 that causes features of the Down syndrome phenotype. Am J Hum Genet 47:236-246.
20. Korenberg JR, Bradley C, Disteche CM. 1992. Down syndrome: Molecular mapping of the congenital heart disease and duodenal stenosis. Am J Hum Genet. 50:294-302.
21. Kuribayashi T, Roberts WC. 1993. Tetralogy of Fallot, truncus arteriosus, abnormal myocardial architecture and anomalies of the aortic arch system induced by bis-diamine in rat fetuses. J Am Coll Cardiol 21:768-776.
22. Leatherbury L, Connuck DM, Kirby ML. 1993. Neural crest ablation versus sham surgical effects in a chick embryo model of defective cardiovascular development. Pediatr Res 33:628-631.
23. Matsuoka R, Takao A, Kimura M, Imamura S, Kondo C, Joh-o K, Ikeda K, Nishibatake M, Ando M, Momma K. 1994. Confirmation that the conotruncal anomaly face syndrome is associated with a deletion within 22q11.2. Am J Med Genet 53:285-289.
24. McCormick MK, Schinzel A, Petersen MB, Stetten G, Driscoll DJ, Cantu ES, Tranebjaerg L, Mikkelsen M, Watkins PC, Antonarakis SE. 1989. Molecular genetic approach to the characterization of the "Down syndrome region"of chromosome 21. Genomics 5:325-331.
25. Miyagawa-Tomita S, Waldo K, Tomita H, Kirby ML. 1991. Temporospatial study of the migration and distribution of cardiac neural crest in quail-chick chimeras. Am J Anat 192:79-88.
26. Mjaatvedt CH, Lepera RC, Markwald RR. 1987. Myocardial specificity for initiating endothelial-mesenchymal cell transition in embryonic chick heart correlates with a particulate distribution of fibronectin. Dev Biol 119:59-67.
27. Mjaatvedt CH, Markwald RR. 1989. Induction of an epithelial-mesenchymal transition by an in vivo adheron-like complex [published erratum appears in Dev Biol 1990;137:217]. Dev Biol 136:118-128.
28. Mjaatvedt CH, Krug EL, Markwald RR. 1991. An antiserum (ES1) against a particulate form of extracellular matrix blocks the transition of cardiac endothelium into mesenchyme in culture. Dev Biol 145:219-230.
29. Momma K, Ando M. 1994. Fetal cardiovascular morphology of interrupted aortic arch type B in rats. Fetal Diagn Ther 9:44-52.
30. Morgan J, Garrod D. 1984. HeLa cells form focal contacts that are not fibronectin dependent. J Cell Sci 66:133-145.
31. Nishibatake M, Kirby ML, Van Mierop LH. 1987. Pathogenesis of persistent truncus arteriosus and dextroposed aorta in the chick embryo after neural crest ablation. Circulation 75:255-264.
32. Ohira M, Ichikawa H, Suzuki E, Iwaki M, Suzuki K, Saito-Ohara F, Ikeuchi T, Chumakov I, Tanahashi H, Tashiro K, Sakaki Y. 1996. A 1.6-Mb P1-based physical map of the Down syndrome region on chromosome 21. Genomics 33:65-74.
33. Okamoto N, Satow Y, Lee JY, Sumida H, Hayakawa K, Ohdo S, Okishima T. 1984. Morphology and pathogenesis of the cardiovascular anomalies induced by bis-(dichloroacetyl) diamine in rats. In: Takao A, Nora JJ, editors. Congenital heart disease: Cause and processes. Mount Kisco: Futura Publishing Company. p 199-221.
34. Okishima T, Takamura K, Matsuoka Y, Ohdo S, Hayakawa K. 1992. Cardiovascular anomalies in chick embryos produced by bisdiamine in dimethylsulfoxide. Teratology 45:155-162.
35. Pangalos C, Theophile D, Sinet PM, Marks A, Stamboulieh-Abazis D, Chettouh Z, Prieur M, Verellen C, Rethore MO, Lejeune J, Delabar J. 1992. No significant effect of monosomy for distal 21q22.3 on the Down syndrome phenotype in "mirror" duplications of chromosome 21. Am J Hum Genet 51:1240-1250.
36. Polinger IS. 1970. Separation of cell types in embryonic heart cell cultures. Exp Cell Res 63:78-82.
37. Potts JD, Runyan RB. 1989. Epithelial-mesenchymal cell transformation in the embryonic heart can be mediated, in part, by transforming growth factor beta. Dev Biol 134:392-401.
38. Potts JD, Dagle JM, Walder JA, Weeks DL, Runyan RB. 1991. Epithelial-mesenchymal transformation of embryonic cardiac endothelial cells is inhibited by a modified antisense oligodeoxynucleotide to transforming growth factor beta 3. Proc Natl Acad Sci USA 88:1516-1520.
39. Rahmani Z, Blouin JL, Creau-Goldberg N, Watkins PC, Mattei JF, Poissonnier M, Prieur M, Chettouh Z, Nicole A, Aurias A, Sinet P, Delabar J. 1989. Critical role of the D21S55 region on chromosome 21 in the pathogenesis of Down syndrome. Proc Natl Acad Sci USA 86:5958-5962.
40. Takahashi K, Kido S, Hoshino K, Ogawa K, Ohashi H, Fukushima Y. 1995. Frequency of a 22q11 deletion in patients with conotruncal cardiac malformations: A prospective study. Eur J Pediatr 154:878-881.
41. Takamura K, Okishima T, Ohdo S, Hayakawa K. 1990. Association of cephalic neural crest cells with cardiovascular development, particularly that of the semilunar valves. Anat Embryol (Berl) 182:263-272.
42. Tasaka H, Takenaka H, Okamoto N, Onitsuka T, Koga Y, Hamada M. 1991. Abnormal development of cardiovascular systems in rat embryos treated with bisdiamine. Teratology 43:191-200.
43. Tasaka H, Okamoto N, Takenaka H, Koga Y, Hamada M. 1993. Atrioventricular septal defect in rat fetuses induced by administration of bisdiamine. Congenital Anom 33:31-44.
44. Yamada KM. 1978. Immunological characterization of a major transformation-sensitive fibroblast cell surface glycoprotein. J Cell Biol 78:520-541.